Multilayer Adjuvanted Influenza Protein Nanoparticles Improve Intranasal Delivery and Antigen-Specific Immunity Article Swipe
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1021/acsnano.4c14735
Intranasal vaccination is a desired route for protection against influenza viruses by mucosal and systemic immunity. However, the nasal mucosa impedes the intranasal delivery of vaccines. Here, we formulated layer-by-layer (LBL) influenza vaccine nanoparticles for effective intranasal delivery by coating them with alternating mucoadhesive cationic chitosan and muco-inert anionic CpG adjuvants. The nanoparticle cores were formed by desolvating influenza M2e antigen and coating it with hemagglutinin (HA) antigen via biotin-streptavidin conjugation. LBL modification promoted nasal delivery and interaction with the resident immune cells. Intranasal administration with LBL nanoparticles significantly improved cellular and humoral immune responses against HA and M2e including high IgA titers, a hallmark of potent mucosal immunity and persistence of immune responses. Distinct trends for antigen-specific immune responses were observed for different routes of vaccination. The enhanced immune responses conferred mice protection against the influenza challenge and prominently reduced viral titers, demonstrating the effectiveness of intranasal LBL vaccine nanoparticles.
Related Topics
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1021/acsnano.4c14735
- OA Status
- hybrid
- Cited By
- 5
- References
- 114
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4407594881
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4407594881Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1021/acsnano.4c14735Digital Object Identifier
- Title
-
Multilayer Adjuvanted Influenza Protein Nanoparticles Improve Intranasal Delivery and Antigen-Specific ImmunityWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-02-15Full publication date if available
- Authors
-
Jaeyoung Park, Thomas Pho, Noopur Bhatnagar, D. Linh, Mariela R. Rodriguez-Otero, Surya Sekhar Pal, Chau Thuy Tien Le, Steven Jenison, Chenyu Li, Gemma E. May, Marisa Arioka, Sang‐Moo Kang, Julie A. ChampionList of authors in order
- Landing page
-
https://doi.org/10.1021/acsnano.4c14735Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
hybridOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1021/acsnano.4c14735Direct OA link when available
- Concepts
-
Nasal administration, Antigen, Immunity, Virology, Nanoparticle, Medicine, Immunology, Immune system, Nanotechnology, Materials scienceTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
5Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 5Per-year citation counts (last 5 years)
- References (count)
-
114Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4407594881 |
|---|---|
| doi | https://doi.org/10.1021/acsnano.4c14735 |
| ids.doi | https://doi.org/10.1021/acsnano.4c14735 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/39954231 |
| ids.openalex | https://openalex.org/W4407594881 |
| fwci | 23.00675248 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D000281 |
| mesh[0].is_major_topic | True |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Administration, Intranasal |
| mesh[1].qualifier_ui | |
| mesh[1].descriptor_ui | D000818 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | |
| mesh[1].descriptor_name | Animals |
| mesh[2].qualifier_ui | Q000737 |
| mesh[2].descriptor_ui | D053758 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | chemistry |
| mesh[2].descriptor_name | Nanoparticles |
| mesh[3].qualifier_ui | Q000276 |
| mesh[3].descriptor_ui | D007252 |
| mesh[3].is_major_topic | True |
| mesh[3].qualifier_name | immunology |
| mesh[3].descriptor_name | Influenza Vaccines |
| mesh[4].qualifier_ui | Q000008 |
| mesh[4].descriptor_ui | D007252 |
| mesh[4].is_major_topic | True |
| mesh[4].qualifier_name | administration & dosage |
| mesh[4].descriptor_name | Influenza Vaccines |
| mesh[5].qualifier_ui | Q000737 |
| mesh[5].descriptor_ui | D007252 |
| mesh[5].is_major_topic | True |
| mesh[5].qualifier_name | chemistry |
| mesh[5].descriptor_name | Influenza Vaccines |
| mesh[6].qualifier_ui | |
| mesh[6].descriptor_ui | D051379 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | |
| mesh[6].descriptor_name | Mice |
| mesh[7].qualifier_ui | |
| mesh[7].descriptor_ui | D008807 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | |
| mesh[7].descriptor_name | Mice, Inbred BALB C |
| mesh[8].qualifier_ui | Q000737 |
| mesh[8].descriptor_ui | D000276 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | chemistry |
| mesh[8].descriptor_name | Adjuvants, Immunologic |
| mesh[9].qualifier_ui | Q000008 |
| mesh[9].descriptor_ui | D000276 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | administration & dosage |
| mesh[9].descriptor_name | Adjuvants, Immunologic |
| mesh[10].qualifier_ui | Q000494 |
| mesh[10].descriptor_ui | D000276 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | pharmacology |
| mesh[10].descriptor_name | Adjuvants, Immunologic |
| mesh[11].qualifier_ui | |
| mesh[11].descriptor_ui | D005260 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | |
| mesh[11].descriptor_name | Female |
| mesh[12].qualifier_ui | Q000737 |
| mesh[12].descriptor_ui | D048271 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | chemistry |
| mesh[12].descriptor_name | Chitosan |
| mesh[13].qualifier_ui | Q000517 |
| mesh[13].descriptor_ui | D009976 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | prevention & control |
| mesh[13].descriptor_name | Orthomyxoviridae Infections |
| mesh[14].qualifier_ui | Q000276 |
| mesh[14].descriptor_ui | D009976 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | immunology |
| mesh[14].descriptor_name | Orthomyxoviridae Infections |
| mesh[15].qualifier_ui | Q000276 |
| mesh[15].descriptor_ui | D019267 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | immunology |
| mesh[15].descriptor_name | Hemagglutinin Glycoproteins, Influenza Virus |
| mesh[16].qualifier_ui | Q000737 |
| mesh[16].descriptor_ui | D019267 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | chemistry |
| mesh[16].descriptor_name | Hemagglutinin Glycoproteins, Influenza Virus |
| mesh[17].qualifier_ui | |
| mesh[17].descriptor_ui | D000281 |
| mesh[17].is_major_topic | True |
| mesh[17].qualifier_name | |
| mesh[17].descriptor_name | Administration, Intranasal |
| mesh[18].qualifier_ui | |
| mesh[18].descriptor_ui | D000818 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | |
| mesh[18].descriptor_name | Animals |
| mesh[19].qualifier_ui | Q000737 |
| mesh[19].descriptor_ui | D053758 |
| mesh[19].is_major_topic | True |
| mesh[19].qualifier_name | chemistry |
| mesh[19].descriptor_name | Nanoparticles |
| mesh[20].qualifier_ui | Q000276 |
| mesh[20].descriptor_ui | D007252 |
| mesh[20].is_major_topic | True |
| mesh[20].qualifier_name | immunology |
| mesh[20].descriptor_name | Influenza Vaccines |
| mesh[21].qualifier_ui | Q000008 |
| mesh[21].descriptor_ui | D007252 |
| mesh[21].is_major_topic | True |
| mesh[21].qualifier_name | administration & dosage |
| mesh[21].descriptor_name | Influenza Vaccines |
| mesh[22].qualifier_ui | Q000737 |
| mesh[22].descriptor_ui | D007252 |
| mesh[22].is_major_topic | True |
| mesh[22].qualifier_name | chemistry |
| mesh[22].descriptor_name | Influenza Vaccines |
| mesh[23].qualifier_ui | |
| mesh[23].descriptor_ui | D051379 |
| mesh[23].is_major_topic | False |
| mesh[23].qualifier_name | |
| mesh[23].descriptor_name | Mice |
| mesh[24].qualifier_ui | |
| mesh[24].descriptor_ui | D008807 |
| mesh[24].is_major_topic | False |
| mesh[24].qualifier_name | |
| mesh[24].descriptor_name | Mice, Inbred BALB C |
| mesh[25].qualifier_ui | Q000737 |
| mesh[25].descriptor_ui | D000276 |
| mesh[25].is_major_topic | False |
| mesh[25].qualifier_name | chemistry |
| mesh[25].descriptor_name | Adjuvants, Immunologic |
| mesh[26].qualifier_ui | Q000008 |
| mesh[26].descriptor_ui | D000276 |
| mesh[26].is_major_topic | False |
| mesh[26].qualifier_name | administration & dosage |
| mesh[26].descriptor_name | Adjuvants, Immunologic |
| mesh[27].qualifier_ui | Q000494 |
| mesh[27].descriptor_ui | D000276 |
| mesh[27].is_major_topic | False |
| mesh[27].qualifier_name | pharmacology |
| mesh[27].descriptor_name | Adjuvants, Immunologic |
| mesh[28].qualifier_ui | |
| mesh[28].descriptor_ui | D005260 |
| mesh[28].is_major_topic | False |
| mesh[28].qualifier_name | |
| mesh[28].descriptor_name | Female |
| mesh[29].qualifier_ui | Q000737 |
| mesh[29].descriptor_ui | D048271 |
| mesh[29].is_major_topic | False |
| mesh[29].qualifier_name | chemistry |
| mesh[29].descriptor_name | Chitosan |
| mesh[30].qualifier_ui | Q000517 |
| mesh[30].descriptor_ui | D009976 |
| mesh[30].is_major_topic | False |
| mesh[30].qualifier_name | prevention & control |
| mesh[30].descriptor_name | Orthomyxoviridae Infections |
| mesh[31].qualifier_ui | Q000276 |
| mesh[31].descriptor_ui | D009976 |
| mesh[31].is_major_topic | False |
| mesh[31].qualifier_name | immunology |
| mesh[31].descriptor_name | Orthomyxoviridae Infections |
| mesh[32].qualifier_ui | Q000276 |
| mesh[32].descriptor_ui | D019267 |
| mesh[32].is_major_topic | False |
| mesh[32].qualifier_name | immunology |
| mesh[32].descriptor_name | Hemagglutinin Glycoproteins, Influenza Virus |
| mesh[33].qualifier_ui | Q000737 |
| mesh[33].descriptor_ui | D019267 |
| mesh[33].is_major_topic | False |
| mesh[33].qualifier_name | chemistry |
| mesh[33].descriptor_name | Hemagglutinin Glycoproteins, Influenza Virus |
| mesh[34].qualifier_ui | |
| mesh[34].descriptor_ui | D000281 |
| mesh[34].is_major_topic | True |
| mesh[34].qualifier_name | |
| mesh[34].descriptor_name | Administration, Intranasal |
| mesh[35].qualifier_ui | |
| mesh[35].descriptor_ui | D000818 |
| mesh[35].is_major_topic | False |
| mesh[35].qualifier_name | |
| mesh[35].descriptor_name | Animals |
| mesh[36].qualifier_ui | Q000737 |
| mesh[36].descriptor_ui | D053758 |
| mesh[36].is_major_topic | True |
| mesh[36].qualifier_name | chemistry |
| mesh[36].descriptor_name | Nanoparticles |
| mesh[37].qualifier_ui | Q000276 |
| mesh[37].descriptor_ui | D007252 |
| mesh[37].is_major_topic | True |
| mesh[37].qualifier_name | immunology |
| mesh[37].descriptor_name | Influenza Vaccines |
| mesh[38].qualifier_ui | Q000008 |
| mesh[38].descriptor_ui | D007252 |
| mesh[38].is_major_topic | True |
| mesh[38].qualifier_name | administration & dosage |
| mesh[38].descriptor_name | Influenza Vaccines |
| mesh[39].qualifier_ui | Q000737 |
| mesh[39].descriptor_ui | D007252 |
| mesh[39].is_major_topic | True |
| mesh[39].qualifier_name | chemistry |
| mesh[39].descriptor_name | Influenza Vaccines |
| mesh[40].qualifier_ui | |
| mesh[40].descriptor_ui | D051379 |
| mesh[40].is_major_topic | False |
| mesh[40].qualifier_name | |
| mesh[40].descriptor_name | Mice |
| mesh[41].qualifier_ui | |
| mesh[41].descriptor_ui | D008807 |
| mesh[41].is_major_topic | False |
| mesh[41].qualifier_name | |
| mesh[41].descriptor_name | Mice, Inbred BALB C |
| mesh[42].qualifier_ui | Q000737 |
| mesh[42].descriptor_ui | D000276 |
| mesh[42].is_major_topic | False |
| mesh[42].qualifier_name | chemistry |
| mesh[42].descriptor_name | Adjuvants, Immunologic |
| mesh[43].qualifier_ui | Q000008 |
| mesh[43].descriptor_ui | D000276 |
| mesh[43].is_major_topic | False |
| mesh[43].qualifier_name | administration & dosage |
| mesh[43].descriptor_name | Adjuvants, Immunologic |
| mesh[44].qualifier_ui | Q000494 |
| mesh[44].descriptor_ui | D000276 |
| mesh[44].is_major_topic | False |
| mesh[44].qualifier_name | pharmacology |
| mesh[44].descriptor_name | Adjuvants, Immunologic |
| mesh[45].qualifier_ui | |
| mesh[45].descriptor_ui | D005260 |
| mesh[45].is_major_topic | False |
| mesh[45].qualifier_name | |
| mesh[45].descriptor_name | Female |
| mesh[46].qualifier_ui | Q000737 |
| mesh[46].descriptor_ui | D048271 |
| mesh[46].is_major_topic | False |
| mesh[46].qualifier_name | chemistry |
| mesh[46].descriptor_name | Chitosan |
| mesh[47].qualifier_ui | Q000517 |
| mesh[47].descriptor_ui | D009976 |
| mesh[47].is_major_topic | False |
| mesh[47].qualifier_name | prevention & control |
| mesh[47].descriptor_name | Orthomyxoviridae Infections |
| mesh[48].qualifier_ui | Q000276 |
| mesh[48].descriptor_ui | D009976 |
| mesh[48].is_major_topic | False |
| mesh[48].qualifier_name | immunology |
| mesh[48].descriptor_name | Orthomyxoviridae Infections |
| mesh[49].qualifier_ui | Q000276 |
| mesh[49].descriptor_ui | D019267 |
| mesh[49].is_major_topic | False |
| mesh[49].qualifier_name | immunology |
| mesh[49].descriptor_name | Hemagglutinin Glycoproteins, Influenza Virus |
| type | article |
| title | Multilayer Adjuvanted Influenza Protein Nanoparticles Improve Intranasal Delivery and Antigen-Specific Immunity |
| biblio.issue | 7 |
| biblio.volume | 19 |
| biblio.last_page | 7025 |
| biblio.first_page | 7005 |
| grants[0].funder | https://openalex.org/F4320306076 |
| grants[0].award_id | DGE-2039655 |
| grants[0].funder_display_name | National Science Foundation |
| grants[1].funder | https://openalex.org/F4320337355 |
| grants[1].award_id | AI154656 |
| grants[1].funder_display_name | National Institute of Allergy and Infectious Diseases |
| grants[2].funder | https://openalex.org/F4320337392 |
| grants[2].award_id | ECCS-2025462 |
| grants[2].funder_display_name | Division of Electrical, Communications and Cyber Systems |
| topics[0].id | https://openalex.org/T10167 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9995999932289124 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2713 |
| topics[0].subfield.display_name | Epidemiology |
| topics[0].display_name | Influenza Virus Research Studies |
| topics[1].id | https://openalex.org/T10873 |
| topics[1].field.id | https://openalex.org/fields/24 |
| topics[1].field.display_name | Immunology and Microbiology |
| topics[1].score | 0.9980000257492065 |
| topics[1].domain.id | https://openalex.org/domains/1 |
| topics[1].domain.display_name | Life Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2404 |
| topics[1].subfield.display_name | Microbiology |
| topics[1].display_name | Bacterial Infections and Vaccines |
| topics[2].id | https://openalex.org/T10371 |
| topics[2].field.id | https://openalex.org/fields/24 |
| topics[2].field.display_name | Immunology and Microbiology |
| topics[2].score | 0.9976000189781189 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2403 |
| topics[2].subfield.display_name | Immunology |
| topics[2].display_name | Immune Response and Inflammation |
| funders[0].id | https://openalex.org/F4320306076 |
| funders[0].ror | https://ror.org/021nxhr62 |
| funders[0].display_name | National Science Foundation |
| funders[1].id | https://openalex.org/F4320337355 |
| funders[1].ror | https://ror.org/043z4tv69 |
| funders[1].display_name | National Institute of Allergy and Infectious Diseases |
| funders[2].id | https://openalex.org/F4320337392 |
| funders[2].ror | https://ror.org/01krpsy48 |
| funders[2].display_name | Division of Electrical, Communications and Cyber Systems |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C85663871 |
| concepts[0].level | 2 |
| concepts[0].score | 0.8265535831451416 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q6966562 |
| concepts[0].display_name | Nasal administration |
| concepts[1].id | https://openalex.org/C147483822 |
| concepts[1].level | 2 |
| concepts[1].score | 0.5602110624313354 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q103537 |
| concepts[1].display_name | Antigen |
| concepts[2].id | https://openalex.org/C2779341262 |
| concepts[2].level | 3 |
| concepts[2].score | 0.5148572325706482 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q182581 |
| concepts[2].display_name | Immunity |
| concepts[3].id | https://openalex.org/C159047783 |
| concepts[3].level | 1 |
| concepts[3].score | 0.4713023900985718 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q7215 |
| concepts[3].display_name | Virology |
| concepts[4].id | https://openalex.org/C155672457 |
| concepts[4].level | 2 |
| concepts[4].score | 0.4596954882144928 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q61231 |
| concepts[4].display_name | Nanoparticle |
| concepts[5].id | https://openalex.org/C71924100 |
| concepts[5].level | 0 |
| concepts[5].score | 0.37567338347435 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[5].display_name | Medicine |
| concepts[6].id | https://openalex.org/C203014093 |
| concepts[6].level | 1 |
| concepts[6].score | 0.37216487526893616 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[6].display_name | Immunology |
| concepts[7].id | https://openalex.org/C8891405 |
| concepts[7].level | 2 |
| concepts[7].score | 0.35564374923706055 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q1059 |
| concepts[7].display_name | Immune system |
| concepts[8].id | https://openalex.org/C171250308 |
| concepts[8].level | 1 |
| concepts[8].score | 0.32693570852279663 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q11468 |
| concepts[8].display_name | Nanotechnology |
| concepts[9].id | https://openalex.org/C192562407 |
| concepts[9].level | 0 |
| concepts[9].score | 0.3260473906993866 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q228736 |
| concepts[9].display_name | Materials science |
| keywords[0].id | https://openalex.org/keywords/nasal-administration |
| keywords[0].score | 0.8265535831451416 |
| keywords[0].display_name | Nasal administration |
| keywords[1].id | https://openalex.org/keywords/antigen |
| keywords[1].score | 0.5602110624313354 |
| keywords[1].display_name | Antigen |
| keywords[2].id | https://openalex.org/keywords/immunity |
| keywords[2].score | 0.5148572325706482 |
| keywords[2].display_name | Immunity |
| keywords[3].id | https://openalex.org/keywords/virology |
| keywords[3].score | 0.4713023900985718 |
| keywords[3].display_name | Virology |
| keywords[4].id | https://openalex.org/keywords/nanoparticle |
| keywords[4].score | 0.4596954882144928 |
| keywords[4].display_name | Nanoparticle |
| keywords[5].id | https://openalex.org/keywords/medicine |
| keywords[5].score | 0.37567338347435 |
| keywords[5].display_name | Medicine |
| keywords[6].id | https://openalex.org/keywords/immunology |
| keywords[6].score | 0.37216487526893616 |
| keywords[6].display_name | Immunology |
| keywords[7].id | https://openalex.org/keywords/immune-system |
| keywords[7].score | 0.35564374923706055 |
| keywords[7].display_name | Immune system |
| keywords[8].id | https://openalex.org/keywords/nanotechnology |
| keywords[8].score | 0.32693570852279663 |
| keywords[8].display_name | Nanotechnology |
| keywords[9].id | https://openalex.org/keywords/materials-science |
| keywords[9].score | 0.3260473906993866 |
| keywords[9].display_name | Materials science |
| language | en |
| locations[0].id | doi:10.1021/acsnano.4c14735 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S145476921 |
| locations[0].source.issn | 1936-0851, 1936-086X |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 1936-0851 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | ACS Nano |
| locations[0].source.host_organization | https://openalex.org/P4310320006 |
| locations[0].source.host_organization_name | American Chemical Society |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320006 |
| locations[0].license | cc-by |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | ACS Nano |
| locations[0].landing_page_url | https://doi.org/10.1021/acsnano.4c14735 |
| locations[1].id | pmid:39954231 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | ACS nano |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/39954231 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:11867023 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | cc-by |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | https://openalex.org/licenses/cc-by |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | ACS Nano |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/11867023 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5060132590 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-2718-0852 |
| authorships[0].author.display_name | Jaeyoung Park |
| authorships[0].countries | US |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I130701444 |
| authorships[0].affiliations[0].raw_affiliation_string | Georgia Institute of Technology |
| authorships[0].affiliations[1].institution_ids | https://openalex.org/I130701444 |
| authorships[0].affiliations[1].raw_affiliation_string | School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332, United States |
| authorships[0].institutions[0].id | https://openalex.org/I130701444 |
| authorships[0].institutions[0].ror | https://ror.org/01zkghx44 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I130701444 |
| authorships[0].institutions[0].country_code | US |
| authorships[0].institutions[0].display_name | Georgia Institute of Technology |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Jaeyoung Park |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Georgia Institute of Technology, School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332, United States |
| authorships[1].author.id | https://openalex.org/A5065112589 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-6131-2233 |
| authorships[1].author.display_name | Thomas Pho |
| authorships[1].countries | RU, US |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210145583 |
| authorships[1].affiliations[0].raw_affiliation_string | Bioengineering Program |
| authorships[1].affiliations[1].institution_ids | https://openalex.org/I130701444 |
| authorships[1].affiliations[1].raw_affiliation_string | Bioengineering Program, Georgia Institute of Technology, Atlanta, Georgia 30332, United States |
| authorships[1].affiliations[2].institution_ids | https://openalex.org/I130701444 |
| authorships[1].affiliations[2].raw_affiliation_string | Georgia Institute of Technology |
| authorships[1].affiliations[3].institution_ids | https://openalex.org/I130701444 |
| authorships[1].affiliations[3].raw_affiliation_string | School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332, United States |
| authorships[1].institutions[0].id | https://openalex.org/I4210145583 |
| authorships[1].institutions[0].ror | https://ror.org/04f0ydx59 |
| authorships[1].institutions[0].type | facility |
| authorships[1].institutions[0].lineage | https://openalex.org/I1313323035, https://openalex.org/I4210145583 |
| authorships[1].institutions[0].country_code | RU |
| authorships[1].institutions[0].display_name | Bioengineering Center |
| authorships[1].institutions[1].id | https://openalex.org/I130701444 |
| authorships[1].institutions[1].ror | https://ror.org/01zkghx44 |
| authorships[1].institutions[1].type | education |
| authorships[1].institutions[1].lineage | https://openalex.org/I130701444 |
| authorships[1].institutions[1].country_code | US |
| authorships[1].institutions[1].display_name | Georgia Institute of Technology |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Thomas Pho |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Bioengineering Program, Bioengineering Program, Georgia Institute of Technology, Atlanta, Georgia 30332, United States, Georgia Institute of Technology, School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332, United States |
| authorships[2].author.id | https://openalex.org/A5034758466 |
| authorships[2].author.orcid | https://orcid.org/0000-0001-9260-3957 |
| authorships[2].author.display_name | Noopur Bhatnagar |
| authorships[2].countries | US |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I181565077 |
| authorships[2].affiliations[0].raw_affiliation_string | Georgia State University |
| authorships[2].affiliations[1].institution_ids | https://openalex.org/I181565077 |
| authorships[2].affiliations[1].raw_affiliation_string | Center for Inflammation, Immunity & Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, Georgia 30302, United States |
| authorships[2].institutions[0].id | https://openalex.org/I181565077 |
| authorships[2].institutions[0].ror | https://ror.org/03qt6ba18 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I181565077 |
| authorships[2].institutions[0].country_code | US |
| authorships[2].institutions[0].display_name | Georgia State University |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Noopur Bhatnagar |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Center for Inflammation, Immunity & Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, Georgia 30302, United States, Georgia State University |
| authorships[3].author.id | https://openalex.org/A5055570461 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-5774-9931 |
| authorships[3].author.display_name | D. Linh |
| authorships[3].countries | US |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I130701444 |
| authorships[3].affiliations[0].raw_affiliation_string | School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332, United States |
| authorships[3].affiliations[1].institution_ids | https://openalex.org/I130701444 |
| authorships[3].affiliations[1].raw_affiliation_string | Georgia Institute of Technology |
| authorships[3].institutions[0].id | https://openalex.org/I130701444 |
| authorships[3].institutions[0].ror | https://ror.org/01zkghx44 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I130701444 |
| authorships[3].institutions[0].country_code | US |
| authorships[3].institutions[0].display_name | Georgia Institute of Technology |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Linh D. Mai |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Georgia Institute of Technology, School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332, United States |
| authorships[4].author.id | https://openalex.org/A5020602487 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-6213-769X |
| authorships[4].author.display_name | Mariela R. Rodriguez-Otero |
| authorships[4].countries | RU, US |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I130701444 |
| authorships[4].affiliations[0].raw_affiliation_string | Georgia Institute of Technology |
| authorships[4].affiliations[1].institution_ids | https://openalex.org/I130701444 |
| authorships[4].affiliations[1].raw_affiliation_string | Bioengineering Program, Georgia Institute of Technology, Atlanta, Georgia 30332, United States |
| authorships[4].affiliations[2].institution_ids | https://openalex.org/I130701444 |
| authorships[4].affiliations[2].raw_affiliation_string | School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332, United States |
| authorships[4].affiliations[3].institution_ids | https://openalex.org/I4210145583 |
| authorships[4].affiliations[3].raw_affiliation_string | Bioengineering Program |
| authorships[4].institutions[0].id | https://openalex.org/I4210145583 |
| authorships[4].institutions[0].ror | https://ror.org/04f0ydx59 |
| authorships[4].institutions[0].type | facility |
| authorships[4].institutions[0].lineage | https://openalex.org/I1313323035, https://openalex.org/I4210145583 |
| authorships[4].institutions[0].country_code | RU |
| authorships[4].institutions[0].display_name | Bioengineering Center |
| authorships[4].institutions[1].id | https://openalex.org/I130701444 |
| authorships[4].institutions[1].ror | https://ror.org/01zkghx44 |
| authorships[4].institutions[1].type | education |
| authorships[4].institutions[1].lineage | https://openalex.org/I130701444 |
| authorships[4].institutions[1].country_code | US |
| authorships[4].institutions[1].display_name | Georgia Institute of Technology |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Mariela R. Rodriguez-Otero |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Bioengineering Program, Bioengineering Program, Georgia Institute of Technology, Atlanta, Georgia 30332, United States, Georgia Institute of Technology, School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332, United States |
| authorships[5].author.id | https://openalex.org/A5008733283 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Surya Sekhar Pal |
| authorships[5].countries | US |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I181565077 |
| authorships[5].affiliations[0].raw_affiliation_string | Georgia State University |
| authorships[5].affiliations[1].institution_ids | https://openalex.org/I181565077 |
| authorships[5].affiliations[1].raw_affiliation_string | Center for Inflammation, Immunity & Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, Georgia 30302, United States |
| authorships[5].institutions[0].id | https://openalex.org/I181565077 |
| authorships[5].institutions[0].ror | https://ror.org/03qt6ba18 |
| authorships[5].institutions[0].type | education |
| authorships[5].institutions[0].lineage | https://openalex.org/I181565077 |
| authorships[5].institutions[0].country_code | US |
| authorships[5].institutions[0].display_name | Georgia State University |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Surya Sekhar Pal |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Center for Inflammation, Immunity & Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, Georgia 30302, United States, Georgia State University |
| authorships[6].author.id | https://openalex.org/A5013600325 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-8540-2767 |
| authorships[6].author.display_name | Chau Thuy Tien Le |
| authorships[6].countries | US |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I181565077 |
| authorships[6].affiliations[0].raw_affiliation_string | Georgia State University |
| authorships[6].affiliations[1].institution_ids | https://openalex.org/I181565077 |
| authorships[6].affiliations[1].raw_affiliation_string | Center for Inflammation, Immunity & Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, Georgia 30302, United States |
| authorships[6].institutions[0].id | https://openalex.org/I181565077 |
| authorships[6].institutions[0].ror | https://ror.org/03qt6ba18 |
| authorships[6].institutions[0].type | education |
| authorships[6].institutions[0].lineage | https://openalex.org/I181565077 |
| authorships[6].institutions[0].country_code | US |
| authorships[6].institutions[0].display_name | Georgia State University |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Chau Thuy Tien Le |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Center for Inflammation, Immunity & Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, Georgia 30302, United States, Georgia State University |
| authorships[7].author.id | https://openalex.org/A5014517021 |
| authorships[7].author.orcid | |
| authorships[7].author.display_name | Steven Jenison |
| authorships[7].countries | US |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I130701444 |
| authorships[7].affiliations[0].raw_affiliation_string | Georgia Institute of Technology |
| authorships[7].affiliations[1].institution_ids | https://openalex.org/I130701444 |
| authorships[7].affiliations[1].raw_affiliation_string | School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332, United States |
| authorships[7].institutions[0].id | https://openalex.org/I130701444 |
| authorships[7].institutions[0].ror | https://ror.org/01zkghx44 |
| authorships[7].institutions[0].type | education |
| authorships[7].institutions[0].lineage | https://openalex.org/I130701444 |
| authorships[7].institutions[0].country_code | US |
| authorships[7].institutions[0].display_name | Georgia Institute of Technology |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Sarah E. Jenison |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Georgia Institute of Technology, School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332, United States |
| authorships[8].author.id | https://openalex.org/A5100354326 |
| authorships[8].author.orcid | https://orcid.org/0000-0001-8028-6691 |
| authorships[8].author.display_name | Chenyu Li |
| authorships[8].countries | US |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I130701444 |
| authorships[8].affiliations[0].raw_affiliation_string | School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332, United States |
| authorships[8].affiliations[1].institution_ids | https://openalex.org/I130701444 |
| authorships[8].affiliations[1].raw_affiliation_string | Georgia Institute of Technology |
| authorships[8].institutions[0].id | https://openalex.org/I130701444 |
| authorships[8].institutions[0].ror | https://ror.org/01zkghx44 |
| authorships[8].institutions[0].type | education |
| authorships[8].institutions[0].lineage | https://openalex.org/I130701444 |
| authorships[8].institutions[0].country_code | US |
| authorships[8].institutions[0].display_name | Georgia Institute of Technology |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Chenyu Li |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Georgia Institute of Technology, School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332, United States |
| authorships[9].author.id | https://openalex.org/A5088486292 |
| authorships[9].author.orcid | https://orcid.org/0000-0003-1583-2400 |
| authorships[9].author.display_name | Gemma E. May |
| authorships[9].countries | US |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I130701444 |
| authorships[9].affiliations[0].raw_affiliation_string | Georgia Institute of Technology |
| authorships[9].affiliations[1].institution_ids | https://openalex.org/I130701444 |
| authorships[9].affiliations[1].raw_affiliation_string | School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332, United States |
| authorships[9].institutions[0].id | https://openalex.org/I130701444 |
| authorships[9].institutions[0].ror | https://ror.org/01zkghx44 |
| authorships[9].institutions[0].type | education |
| authorships[9].institutions[0].lineage | https://openalex.org/I130701444 |
| authorships[9].institutions[0].country_code | US |
| authorships[9].institutions[0].display_name | Georgia Institute of Technology |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Grace A. May |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Georgia Institute of Technology, School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332, United States |
| authorships[10].author.id | https://openalex.org/A5116278451 |
| authorships[10].author.orcid | |
| authorships[10].author.display_name | Marisa Arioka |
| authorships[10].countries | JP |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I161296585 |
| authorships[10].affiliations[0].raw_affiliation_string | Department of Chemistry, Tokyo University of Science, Shinjuku-ku, Tokyo 162-8601, Japan |
| authorships[10].affiliations[1].institution_ids | https://openalex.org/I161296585 |
| authorships[10].affiliations[1].raw_affiliation_string | Tokyo University of Science |
| authorships[10].institutions[0].id | https://openalex.org/I161296585 |
| authorships[10].institutions[0].ror | https://ror.org/05sj3n476 |
| authorships[10].institutions[0].type | education |
| authorships[10].institutions[0].lineage | https://openalex.org/I161296585 |
| authorships[10].institutions[0].country_code | JP |
| authorships[10].institutions[0].display_name | Tokyo University of Science |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Marisa Arioka |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Department of Chemistry, Tokyo University of Science, Shinjuku-ku, Tokyo 162-8601, Japan, Tokyo University of Science |
| authorships[11].author.id | https://openalex.org/A5091280121 |
| authorships[11].author.orcid | https://orcid.org/0000-0001-6198-331X |
| authorships[11].author.display_name | Sang‐Moo Kang |
| authorships[11].countries | US |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I181565077 |
| authorships[11].affiliations[0].raw_affiliation_string | Center for Inflammation, Immunity & Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, Georgia 30302, United States |
| authorships[11].affiliations[1].institution_ids | https://openalex.org/I181565077 |
| authorships[11].affiliations[1].raw_affiliation_string | Georgia State University |
| authorships[11].institutions[0].id | https://openalex.org/I181565077 |
| authorships[11].institutions[0].ror | https://ror.org/03qt6ba18 |
| authorships[11].institutions[0].type | education |
| authorships[11].institutions[0].lineage | https://openalex.org/I181565077 |
| authorships[11].institutions[0].country_code | US |
| authorships[11].institutions[0].display_name | Georgia State University |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Sang-Moo Kang |
| authorships[11].is_corresponding | True |
| authorships[11].raw_affiliation_strings | Center for Inflammation, Immunity & Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, Georgia 30302, United States, Georgia State University |
| authorships[12].author.id | https://openalex.org/A5038617325 |
| authorships[12].author.orcid | https://orcid.org/0000-0002-0260-9392 |
| authorships[12].author.display_name | Julie A. Champion |
| authorships[12].countries | RU, US |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I130701444 |
| authorships[12].affiliations[0].raw_affiliation_string | School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332, United States |
| authorships[12].affiliations[1].institution_ids | https://openalex.org/I130701444 |
| authorships[12].affiliations[1].raw_affiliation_string | Georgia Institute of Technology |
| authorships[12].affiliations[2].institution_ids | https://openalex.org/I4210145583 |
| authorships[12].affiliations[2].raw_affiliation_string | Bioengineering Program |
| authorships[12].affiliations[3].institution_ids | https://openalex.org/I130701444 |
| authorships[12].affiliations[3].raw_affiliation_string | Bioengineering Program, Georgia Institute of Technology, Atlanta, Georgia 30332, United States |
| authorships[12].institutions[0].id | https://openalex.org/I4210145583 |
| authorships[12].institutions[0].ror | https://ror.org/04f0ydx59 |
| authorships[12].institutions[0].type | facility |
| authorships[12].institutions[0].lineage | https://openalex.org/I1313323035, https://openalex.org/I4210145583 |
| authorships[12].institutions[0].country_code | RU |
| authorships[12].institutions[0].display_name | Bioengineering Center |
| authorships[12].institutions[1].id | https://openalex.org/I130701444 |
| authorships[12].institutions[1].ror | https://ror.org/01zkghx44 |
| authorships[12].institutions[1].type | education |
| authorships[12].institutions[1].lineage | https://openalex.org/I130701444 |
| authorships[12].institutions[1].country_code | US |
| authorships[12].institutions[1].display_name | Georgia Institute of Technology |
| authorships[12].author_position | last |
| authorships[12].raw_author_name | Julie A. Champion |
| authorships[12].is_corresponding | True |
| authorships[12].raw_affiliation_strings | Bioengineering Program, Bioengineering Program, Georgia Institute of Technology, Atlanta, Georgia 30332, United States, Georgia Institute of Technology, School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332, United States |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1021/acsnano.4c14735 |
| open_access.oa_status | hybrid |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Multilayer Adjuvanted Influenza Protein Nanoparticles Improve Intranasal Delivery and Antigen-Specific Immunity |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10167 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9995999932289124 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2713 |
| primary_topic.subfield.display_name | Epidemiology |
| primary_topic.display_name | Influenza Virus Research Studies |
| related_works | https://openalex.org/W2464533852, https://openalex.org/W2392442508, https://openalex.org/W2437174963, https://openalex.org/W2382000653, https://openalex.org/W2360385304, https://openalex.org/W3033094367, https://openalex.org/W4401388679, https://openalex.org/W2893308019, https://openalex.org/W2035726141, https://openalex.org/W844196773 |
| cited_by_count | 5 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 5 |
| locations_count | 3 |
| best_oa_location.id | doi:10.1021/acsnano.4c14735 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S145476921 |
| best_oa_location.source.issn | 1936-0851, 1936-086X |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 1936-0851 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | ACS Nano |
| best_oa_location.source.host_organization | https://openalex.org/P4310320006 |
| best_oa_location.source.host_organization_name | American Chemical Society |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320006 |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | ACS Nano |
| best_oa_location.landing_page_url | https://doi.org/10.1021/acsnano.4c14735 |
| primary_location.id | doi:10.1021/acsnano.4c14735 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S145476921 |
| primary_location.source.issn | 1936-0851, 1936-086X |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 1936-0851 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | ACS Nano |
| primary_location.source.host_organization | https://openalex.org/P4310320006 |
| primary_location.source.host_organization_name | American Chemical Society |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320006 |
| primary_location.license | cc-by |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | ACS Nano |
| primary_location.landing_page_url | https://doi.org/10.1021/acsnano.4c14735 |
| publication_date | 2025-02-15 |
| publication_year | 2025 |
| referenced_works | https://openalex.org/W2754714569, https://openalex.org/W2151568075, https://openalex.org/W2950072531, https://openalex.org/W4200539520, https://openalex.org/W2063432056, https://openalex.org/W3003016299, https://openalex.org/W2790948798, https://openalex.org/W2045290525, https://openalex.org/W1994815114, https://openalex.org/W3159182321, https://openalex.org/W4210440919, https://openalex.org/W2885469050, https://openalex.org/W4376149828, https://openalex.org/W4309837238, https://openalex.org/W4360860804, https://openalex.org/W4297231530, https://openalex.org/W2034253067, https://openalex.org/W2770624586, https://openalex.org/W2485540149, https://openalex.org/W2751690310, https://openalex.org/W1979989636, https://openalex.org/W3126257938, https://openalex.org/W4388337165, https://openalex.org/W4283641637, https://openalex.org/W3089962069, https://openalex.org/W4312211314, https://openalex.org/W4376126838, https://openalex.org/W3074781351, https://openalex.org/W2089301392, https://openalex.org/W3092714928, https://openalex.org/W2943197912, https://openalex.org/W4384819234, https://openalex.org/W1496387147, https://openalex.org/W4308682969, https://openalex.org/W2462917009, https://openalex.org/W2512657324, https://openalex.org/W2910744014, https://openalex.org/W2415712868, https://openalex.org/W2619617218, https://openalex.org/W2102847984, https://openalex.org/W2989731979, https://openalex.org/W2794060446, https://openalex.org/W2754200907, https://openalex.org/W2333733391, https://openalex.org/W2916482773, https://openalex.org/W2987774082, https://openalex.org/W3131094908, https://openalex.org/W2112891300, https://openalex.org/W2035820003, https://openalex.org/W1991936408, https://openalex.org/W2112670248, https://openalex.org/W4313387790, https://openalex.org/W3183321138, https://openalex.org/W2020266608, https://openalex.org/W1843302206, https://openalex.org/W4379386077, https://openalex.org/W3204277088, https://openalex.org/W3145295285, https://openalex.org/W2563995440, https://openalex.org/W2785232134, https://openalex.org/W4317776836, https://openalex.org/W4312118816, https://openalex.org/W4322494336, https://openalex.org/W3080829022, https://openalex.org/W3160834656, https://openalex.org/W4385255005, https://openalex.org/W4389625700, https://openalex.org/W2071629929, https://openalex.org/W2523419623, https://openalex.org/W2613253049, https://openalex.org/W4387845974, https://openalex.org/W2150375936, https://openalex.org/W2030330224, https://openalex.org/W3026505461, https://openalex.org/W4360869954, https://openalex.org/W2015239730, https://openalex.org/W2096428863, https://openalex.org/W2045360275, https://openalex.org/W2292726954, https://openalex.org/W4393302315, https://openalex.org/W4400060372, https://openalex.org/W4400490969, https://openalex.org/W1978505427, https://openalex.org/W2001285947, https://openalex.org/W2046941690, https://openalex.org/W3152567964, https://openalex.org/W2102335249, https://openalex.org/W2576961101, https://openalex.org/W2016943369, https://openalex.org/W2995903145, https://openalex.org/W2099615297, https://openalex.org/W2111078965, https://openalex.org/W2136060817, https://openalex.org/W2959793769, https://openalex.org/W2002200252, https://openalex.org/W4200005742, https://openalex.org/W773735717, https://openalex.org/W4225255155, https://openalex.org/W2098613299, https://openalex.org/W2757687258, https://openalex.org/W2884429253, https://openalex.org/W3196533469, https://openalex.org/W4310577012, https://openalex.org/W2006760510, https://openalex.org/W2988846677, https://openalex.org/W4375859621, https://openalex.org/W4383645721, https://openalex.org/W2089879345, https://openalex.org/W1910012553, https://openalex.org/W2703965028, https://openalex.org/W4386112016, https://openalex.org/W4384939021, https://openalex.org/W2610489194, https://openalex.org/W2256756668 |
| referenced_works_count | 114 |
| abstract_inverted_index.a | 3, 103 |
| abstract_inverted_index.HA | 96 |
| abstract_inverted_index.by | 11, 38, 56 |
| abstract_inverted_index.is | 2 |
| abstract_inverted_index.it | 63 |
| abstract_inverted_index.of | 24, 105, 111, 125, 146 |
| abstract_inverted_index.we | 27 |
| abstract_inverted_index.CpG | 49 |
| abstract_inverted_index.IgA | 101 |
| abstract_inverted_index.LBL | 71, 86, 148 |
| abstract_inverted_index.M2e | 59, 98 |
| abstract_inverted_index.The | 51, 127 |
| abstract_inverted_index.and | 13, 46, 61, 76, 91, 97, 109, 138 |
| abstract_inverted_index.for | 6, 34, 116, 122 |
| abstract_inverted_index.the | 17, 21, 79, 135, 144 |
| abstract_inverted_index.via | 68 |
| abstract_inverted_index.(HA) | 66 |
| abstract_inverted_index.high | 100 |
| abstract_inverted_index.mice | 132 |
| abstract_inverted_index.them | 40 |
| abstract_inverted_index.were | 54, 120 |
| abstract_inverted_index.with | 41, 64, 78, 85 |
| abstract_inverted_index.(LBL) | 30 |
| abstract_inverted_index.Here, | 26 |
| abstract_inverted_index.cores | 53 |
| abstract_inverted_index.nasal | 18, 74 |
| abstract_inverted_index.route | 5 |
| abstract_inverted_index.viral | 141 |
| abstract_inverted_index.cells. | 82 |
| abstract_inverted_index.formed | 55 |
| abstract_inverted_index.immune | 81, 93, 112, 118, 129 |
| abstract_inverted_index.mucosa | 19 |
| abstract_inverted_index.potent | 106 |
| abstract_inverted_index.routes | 124 |
| abstract_inverted_index.trends | 115 |
| abstract_inverted_index.against | 8, 95, 134 |
| abstract_inverted_index.anionic | 48 |
| abstract_inverted_index.antigen | 60, 67 |
| abstract_inverted_index.coating | 39, 62 |
| abstract_inverted_index.desired | 4 |
| abstract_inverted_index.humoral | 92 |
| abstract_inverted_index.impedes | 20 |
| abstract_inverted_index.mucosal | 12, 107 |
| abstract_inverted_index.reduced | 140 |
| abstract_inverted_index.titers, | 102, 142 |
| abstract_inverted_index.vaccine | 32, 149 |
| abstract_inverted_index.viruses | 10 |
| abstract_inverted_index.Distinct | 114 |
| abstract_inverted_index.However, | 16 |
| abstract_inverted_index.cationic | 44 |
| abstract_inverted_index.cellular | 90 |
| abstract_inverted_index.chitosan | 45 |
| abstract_inverted_index.delivery | 23, 37, 75 |
| abstract_inverted_index.enhanced | 128 |
| abstract_inverted_index.hallmark | 104 |
| abstract_inverted_index.immunity | 108 |
| abstract_inverted_index.improved | 89 |
| abstract_inverted_index.observed | 121 |
| abstract_inverted_index.promoted | 73 |
| abstract_inverted_index.resident | 80 |
| abstract_inverted_index.systemic | 14 |
| abstract_inverted_index.challenge | 137 |
| abstract_inverted_index.conferred | 131 |
| abstract_inverted_index.different | 123 |
| abstract_inverted_index.effective | 35 |
| abstract_inverted_index.immunity. | 15 |
| abstract_inverted_index.including | 99 |
| abstract_inverted_index.influenza | 9, 31, 58, 136 |
| abstract_inverted_index.responses | 94, 119, 130 |
| abstract_inverted_index.vaccines. | 25 |
| abstract_inverted_index.Intranasal | 0, 83 |
| abstract_inverted_index.adjuvants. | 50 |
| abstract_inverted_index.formulated | 28 |
| abstract_inverted_index.intranasal | 22, 36, 147 |
| abstract_inverted_index.muco-inert | 47 |
| abstract_inverted_index.protection | 7, 133 |
| abstract_inverted_index.responses. | 113 |
| abstract_inverted_index.alternating | 42 |
| abstract_inverted_index.desolvating | 57 |
| abstract_inverted_index.interaction | 77 |
| abstract_inverted_index.persistence | 110 |
| abstract_inverted_index.prominently | 139 |
| abstract_inverted_index.vaccination | 1 |
| abstract_inverted_index.conjugation. | 70 |
| abstract_inverted_index.modification | 72 |
| abstract_inverted_index.mucoadhesive | 43 |
| abstract_inverted_index.nanoparticle | 52 |
| abstract_inverted_index.vaccination. | 126 |
| abstract_inverted_index.demonstrating | 143 |
| abstract_inverted_index.effectiveness | 145 |
| abstract_inverted_index.hemagglutinin | 65 |
| abstract_inverted_index.nanoparticles | 33, 87 |
| abstract_inverted_index.significantly | 88 |
| abstract_inverted_index.administration | 84 |
| abstract_inverted_index.layer-by-layer | 29 |
| abstract_inverted_index.nanoparticles. | 150 |
| abstract_inverted_index.antigen-specific | 117 |
| abstract_inverted_index.biotin-streptavidin | 69 |
| cited_by_percentile_year.max | 99 |
| cited_by_percentile_year.min | 98 |
| corresponding_author_ids | https://openalex.org/A5038617325, https://openalex.org/A5091280121 |
| countries_distinct_count | 3 |
| institutions_distinct_count | 13 |
| corresponding_institution_ids | https://openalex.org/I130701444, https://openalex.org/I181565077, https://openalex.org/I4210145583 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/2 |
| sustainable_development_goals[0].score | 0.6200000047683716 |
| sustainable_development_goals[0].display_name | Zero hunger |
| citation_normalized_percentile.value | 0.98578918 |
| citation_normalized_percentile.is_in_top_1_percent | True |
| citation_normalized_percentile.is_in_top_10_percent | True |